Next Article in Journal
Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab
Next Article in Special Issue
Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond
Previous Article in Journal
Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study
Previous Article in Special Issue
Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled Analysis
 
 
Review

Article Versions Notes

Cancers 2023, 15(17), 4272; https://doi.org/10.3390/cancers15174272
Action Date Notes Link
article xml file uploaded 26 August 2023 07:47 CEST Original file -
article xml uploaded. 26 August 2023 07:47 CEST Update https://www.mdpi.com/2072-6694/15/17/4272/xml
article pdf uploaded. 26 August 2023 07:47 CEST Version of Record https://www.mdpi.com/2072-6694/15/17/4272/pdf
article html file updated 26 August 2023 07:49 CEST Original file https://www.mdpi.com/2072-6694/15/17/4272/html
Back to TopTop